A Comfort Study of Brinzolamide 1% / Brimonidine 0.2% Fixed Combination, Brinzolamide 1% and Brimonidine 0.2%
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to describe the ocular discomfort immediately upon instillation
of Brinzolamide 1%/Brimonidine 0.2% Tartrate Ophthalmic Suspension, Brinzolamide 1%
Ophthalmic Suspension, and Brimonidine Tartrate 0.2% Ophthalmic Solution in subjects with
open-angle glaucoma and/or ocular hypertension.